4 | Dopamine (Intropin)FDA LinkGeneric
01/2023
-
12/2008 |
4 | Antipsychotic Agents (Antipsychotics)IBA
09/2013
-
01/2007 |
3 | InflammasomesIBA
02/2024
-
01/2018 |
3 | Neurokinin-3 ReceptorsIBA
02/2010
-
01/2008 |
3 | Serotonin (5 Hydroxytryptamine)IBA
04/2008
-
05/2007 |
2 | Ion Channels (Ion Channel)IBA
05/2024
-
11/2007 |
2 | Haloperidol (Haldol)FDA LinkGeneric
01/2021
-
01/2009 |
2 | LipopolysaccharidesIBA
01/2020
-
01/2017 |
2 | Antidepressive Agents (Antidepressants)IBA
12/2013
-
01/2008 |
2 | Vilazodone HydrochlorideIBA
12/2013
-
01/2009 |
2 | LigandsIBA
09/2013
-
01/2010 |
2 | Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2009
-
06/2007 |
2 | serotonin 6 receptorIBA
12/2006
-
02/2004 |
1 | PotassiumIBA
05/2024 |
1 | Adenosine Triphosphate (ATP)IBA
02/2024 |
1 | Orexin ReceptorsIBA
01/2024 |
1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022 |
1 | RNA (Ribonucleic Acid)IBA
01/2021 |
1 | Proteins (Proteins, Gene)FDA Link
01/2021 |
1 | Oxidopamine (6 Hydroxydopamine)IBA
01/2021 |
1 | Protein Isoforms (Isoforms)IBA
01/2020 |
1 | Protein Kinases (Protein Kinase)IBA
01/2020 |
1 | Phosphotransferases (Kinase)IBA
01/2020 |
1 | AMPA Receptors (AMPA Receptor)IBA
01/2017 |
1 | EpitopesIBA
01/2017 |
1 | Glycogen Synthase (Synthase I)IBA
09/2011 |
1 | GSK256471IBA
02/2010 |
1 | 3-amino-N-(cyclopropyl (phenyl)methyl)- 2- (3- fluorophenyl)- 4- quinolinecarboxamideIBA
02/2010 |
1 | TachykininsIBA
02/2010 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
01/2010 |
1 | Fluoxetine (Prozac)FDA LinkGeneric
11/2009 |
1 | Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA
05/2009 |
1 | Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
05/2009 |
1 | Fumigant 93 (D-D)IBA
05/2009 |
1 | Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2009 |
1 | Dopamine D2 Receptor AntagonistsIBA
01/2009 |
1 | 5- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 2- pyrazinecarboxamideIBA
01/2009 |
1 | Amphetamine (Amfetamine)FDA LinkGeneric
01/2009 |
1 | ProlactinIBA
01/2009 |
1 | Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA
01/2009 |
1 | 5-HT1A Serotonin ReceptorIBA
01/2009 |
1 | Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
12/2008 |
1 | Peptides (Polypeptides)IBA
06/2008 |
1 | SB 223412IBA
06/2008 |
1 | N(1)- (6- chloroimidazo(2,1- b)(1,3)thiazole- 5- sulfonyl)tryptamineIBA
05/2008 |
1 | Scopolamine (Hyoscine)FDA Link
04/2008 |
1 | 5-HT1 Serotonin ReceptorsIBA
01/2008 |
1 | gamma-Aminobutyric Acid (GABA)IBA
11/2007 |
1 | 6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA
06/2007 |
1 | AutoreceptorsIBA
05/2007 |
1 | Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
05/2007 |
1 | indoleIBA
01/2007 |
1 | Clozapine (Clozaril)FDA LinkGeneric
01/2007 |
1 | 1,2,3,4,8,9,10,10a- octahydro- 7bH- cyclopenta(b)(1,4)diazepino(6,7,1hj)indoleIBA
01/2007 |
1 | ApomorphineFDA Link
01/2007 |
1 | SB-616234-AIBA
06/2006 |
1 | 5-HT1B Serotonin ReceptorIBA
06/2006 |
1 | Lysophosphatidic Acid ReceptorsIBA
03/2005 |
1 | EnzymesIBA
11/2003 |